Explore how pharma teams, researchers, and CROs use Hyfe CMS to advance cough science, build stronger trials, and bring more effective therapies to patients.
Audience
Indication / Therapeutic Area
Hyfe's CoughMonitor Suite delivered objective cough data that demonstrated a measurable reduction in cough frequency across 12,000+ hours of continuous monitoring and 97.9% median adherence, giving Climatic Health the quantitative evidence their investors and scientific advisors needed to move forward.
26 May 2026
